Zydus Lifesciences Q4 Results: Pharma giant declares 100% dividend and Rs 1,100 crore buyback plan — Check record dates

Zydus Lifesciences reported a steady performance for the quarter and financial year ended FY26, with growth in revenue, EBITDA and net profit on both yearly and sequential basis.

The company also announced a share buyback and a final dividend for shareholders.

Revenue Growth in Q4 and FY26

On a consolidated basis, total income from operations stood at Rs 7,587 crore in Q4 FY26 compared with Rs 6,528 crore in Q4 FY25, a rise of 16.2 per cent year-on-year. On a sequential basis, income rose 10.5 per cent from Rs 6,865 crore in Q3 FY26.

For the full financial year FY26, total income increased to Rs 27,148 crore from Rs 23,242 crore in FY25, up 16.8 per cent year-on-year. The company said the growth was supported by an improvement in operational performance across key segments.

EBITDA Performance

EBITDA for Q4 FY26 stood at Rs 2,554 crore compared with Rs 2,125 crore in Q4 FY25, an increase of 20.2 per cent year-on-year. On a quarter-on-quarter basis, EBITDA rose 40.6 per cent from Rs 1,816 crore in Q3 FY26.

For the full year FY26, EBITDA stood at Rs 8,475 crore compared with Rs 7,059 crore in FY25, up 20.1 per cent year-on-year.

Net Profit Growth

Net profit for Q4 FY26 stood at Rs 1,273 crore compared with Rs 1,171 crore in Q4 FY25, a rise of 8.7 per cent year-on-year. On a sequential basis, net profit increased 22.1 per cent from Rs 1,042 crore in Q3 FY26.

For FY26, net profit rose to Rs 5,040 crore from Rs 4,525 crore in FY25, up 11.4 per cent year-on-year. The company said all key financial parameters showed steady growth during the quarter and the full year, reflecting improved operating performance and higher income from operations.

Buyback Plan Approved

Separately, the board of Zydus Lifesciences approved a proposal to buy back up to 95,65,217 fully paid-up equity shares having a face value of Re 1 each. The shares represent up to 0.95 per cent of the total paid-up equity share capital of the company.

The buyback will be undertaken at Rs 1,150 per equity share, payable in cash. The total buyback size will not exceed Rs 1,100 crore. The company said the buyback size does not include transaction costs such as brokerage fees, taxes, securities transaction tax, goods and services tax, stamp duty and other related expenses.

The offer will be made to all eligible equity shareholders, including promoters and promoter group entities holding shares as on the record date, on a proportionate basis. The board has also formed a buyback committee and delegated powers to it to make necessary decisions related to the process.

The company has fixed May 29, 2026, as the record date for determining shareholder eligibility for participation in the buyback, subject to regulatory requirements.

Final Dividend Announcement

In a separate announcement, the board recommended a final dividend of Re 1 per equity share of face value Re 1 each for FY26, which translates into 100 per cent. The dividend is subject to the approval of shareholders at the annual general meeting.

The record date for the dividend has been fixed as July 24, 2026, for determining eligible shareholders. The company said the dividend payment will be made on or around August 14, 2026, subject to approval at the AGM and applicable tax deductions at source.